Many in vitro and in vivo studies provided substantial evidence that insulin-like growth factor (IGF) and the IGF-1R signaling pathway are the major regulators of growth, survival, migration and invasion in human breast cancer [26], [27]. This evidence concerns the gene IGF1 and breast carcinoma.